Post job

OptimizeRx's revenue is $92.1 million.

What is OptimizeRx's revenue?

OptimizeRx's annual revenue is $92.1M. Zippia's data science team found the following key financial metrics about OptimizeRx after extensive research and analysis.
  • OptimizeRx's revenue growth from 2010 to 2024 is 129,537.66%.
  • OptimizeRx has 37 employees, and the revenue per employee ratio is $2,489,918.
  • OptimizeRx's peak quarterly revenue was $32.3M in 2024(q4).
  • OptimizeRx peak revenue was $92.1M in 2024.
  • OptimizeRx annual revenue for 2023 was 71.5M, 14.53% growth from 2022.
  • OptimizeRx annual revenue for 2024 was 92.1M, 28.81% growth from 2023.

On this page

Most recent quarter revenue
$32.3M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$92.1M (2024)
Company peak revenue
Revenue / employee
$2.5M
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Most recent quarter revenue
$32.3M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$92.1M (2024)
Company peak revenue
Revenue / employee
$2.5M
Company revenue / employee

OptimizeRx historical revenue

OptimizeRx's peak revenue was $92.1M in 2024. The peak quarterly revenue was $32.3M in 2024(q4).

OptimizeRx's revenue increased from $71.1k in 2010 to $92.1M currently. That's a 129,537.66% change in annual revenue.

OptimizeRx annual revenue

$92M
$74M
$55M
$37M
$18M
$0
2019
2020
2021
2022
2023
2024

OptimizeRx annual revenue over time

Fiscal year / yearOptimizeRx revenue
2010$71,065
2011$1.1M
2012$2.0M
2013$4.7M
2014$6.5M
2015$7.2M
2016$7.8M
2017$12.1M
2018$21.2M
2019$24.6M
2020$43.3M
2021$61.3M
2022$62.5M
2023$71.5M
2024$92.1M

Rate OptimizeRx's financial transparency

Zippia waving zebra

OptimizeRx annual growth

OptimizeRx saw the greatest revenue growth in 2011, when revenue increased by 1,464.09%.

OptimizeRx had the lowest revenue growth in 2022, when revenue changed by 1.89%.

OptimizeRx annual growth rate over time

YearOptimizeRx growth
2011
1464%
2012
79%
2013
135%
2014
39%
2015
11%
2016
7%
2017
56%
2018
75%
2019
16%
2020
76%
2021
42%
2022
2%
2023
15%
2024
29%

OptimizeRx quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$32M
$26M
$19M
$13M
$6M
$0
2020
2021
2022
2023
2024

OptimizeRx quarterly growth rate over time

YearQ1Q2Q3Q4
2010$1,283$16,720$40,676$12,386
2011$393,843$200,174$191,593$325,910
2012$329,403$515,423$453,154$691,106
2013$669,448$1.1M$1.4M$1.5M
2014$1.3M$1.4M$1.8M$2.0M
2015$1.5M$1.7M$2.0M$2.0M
2016$1.8M$1.9M$1.8M$2.3M
2017$2.2M$2.9M$3.1M$4.0M
2018$4.1M$5.1M$5.4M$6.6M
2019$5.2M$7.0M$5.0M$7.4M
2020$7.6M$8.8M$10.5M$16.4M
2021$11.2M$13.6M$16.1M$20.3M
2022$13.7M$14.0M$15.1M$19.7M
2023$13.0M$13.8M$16.3M$28.4M
2024$19.7M$18.8M$21.3M$32.3M

OptimizeRx jobs nearby

Do you work at OptimizeRx?

Did OptimizeRx meet its revenue projections?

OptimizeRx financial information

CEOWilliam J. Febbo
IndustryHealth Care Equipment & Services
Company TypePublic
Employees Number37
Date Founded2006
HeadquartersRochester, Michigan
Revenue$92.1M
Net Income-$11,438,440
Gross Proft$59.4M (2024)
EBITDA($9.2M) (2024)
PE Ratio-9.33
Tax Rate-0.0%
Market Capitalization$187.7M
Total Assets$134,651,185
TickerOPRX

OptimizeRx jobs you might like

OptimizeRx financing

OptimizeRx received early financing of $3.0M on 2010-06-08.

SeriesRound sizeDate
Post Ipo Equity$3M06/2010
Post Ipo Equity$9M05/2018

OptimizeRx investors

InvestorsSecurity type
Greyhealth GroupPost-IPO Equity - OPTIMIZERx

OptimizeRx revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of OptimizeRx, including salaries, political affiliations, employee data, and more, in order to inform job seekers about OptimizeRx. The employee data is based on information from people who have self-reported their past or current employments at OptimizeRx. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by OptimizeRx. The data presented on this page does not represent the view of OptimizeRx and its employees or that of Zippia.

OptimizeRx may also be known as or be related to OPTIMIZERX CORP, OPTIMIZERx Corporation, OptimizeRx, OptimizeRx Corp and OptimizeRx Corporation.